| Name | Title | Contact Details |
|---|
SCRI, an industry leader in clinical trials, is dedicated to advancing therapies for patients through clinical research.
Catasys leads the health care industry in improving health and reducing claims costs for health plan members with behavioral health disorders that cause or exacerbate co-existing medical conditions. OnTrak™, a 52-week intensive outpatient program, treats an overlooked population: members suffering from chronic disorders such as substance dependence, anxiety and depression who rarely seek care. These members cost health plans millions of medical dollars primarily due to preventable ambulance usage, medical ER visits and medical inpatient admissions. Catasys uses a proprietary analytics platform and predictive modeling to identify high utilizers of medical healthcare services with costs that can be significantly reduced by addressing the underlying behavioral health disorder(s). Through proactive outreach, we engage and treat these individuals in our patient-centric program that integrates evidence-based medical interventions, psychosocial skill building and care coaching by nurses.
Harvard Bioscience Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Holliston, MA. To find more information about Harvard Bioscience Inc, please visit www.harvardbioscience.com
LE JACQ is a Darien, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Talyst enables positive change in the medication management process.